We investigated HD modifier MMR genes and their cognate heterodimer partners by targeting MutS (MSH2, MSH3, and MSH6), MutL (MLH1, PMS1, PMS2, and MLH3), and LIG1 expression using a CRISPR interference system in HD induced pluripotent stem cells (iPSCs). This evidence concerns the gene MSH2 and Huntington disease.